Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia B”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Large-scale testing (Phase 3)Study completedNCT02250560
What this trial is testing

Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

Who this might be right for
Haemophilia B
Bio Products Laboratory
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Large-scale testing (Phase 3)Study completedNCT00037557
What this trial is testing

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Early research (Phase 1)Study completedNCT00716716
What this trial is testing

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 10
Very early researchUnknownNCT06125756
What this trial is testing

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Who this might be right for
Hemophilia B Without Inhibitor
Affiliated Hospital of Guangdong Medical University 9
Large-scale testing (Phase 3)Study completedNCT01425723
What this trial is testing

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Who this might be right for
Severe Hemophilia B
Bioverativ Therapeutics Inc. 120
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Post-approval studies (Phase 4)UnknownNCT04534751
What this trial is testing

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Who this might be right for
Traumatic HemorrhageCoagulopathyMassive Hemorrhage
University Health Network, Toronto 350
Early research (Phase 1)Study completedNCT03481946
What this trial is testing

Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

Who this might be right for
Hemophilia A; Hemophilia B
Bayer 6
Testing effectiveness (Phase 2)Looking for participantsNCT06379789
What this trial is testing

Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Who this might be right for
Hemophilia B
Regeneron Pharmaceuticals 130
Not applicableUnknownNCT05889754
What this trial is testing

Reliability and Validity of the Turkish Version of the PedHAL

Who this might be right for
HemophiliaHemophilia A, SevereHemophilia B
Hasan Kalyoncu University 50
Post-approval studies (Phase 4)Study completedNCT01561391
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT01335061
What this trial is testing

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Large-scale testing (Phase 3)Looking for participantsNCT06003387
What this trial is testing

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

Who this might be right for
Hemophilia B
CSL Behring 35
Testing effectiveness (Phase 2)Study completedNCT03363321
What this trial is testing

PF-06741086 Long-term Treatment in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Testing effectiveness (Phase 2)Ended earlyNCT02618915
What this trial is testing

Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Load More Results